EVELYN BUTLER: Open Payments
NPI 1093585754 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $951 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Teleflex LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, COBENFY, FANAPT, AUSTEDO XR, UZEDY, INGREZZA, Auvelity, CAPLYTA.
Industry payments across FL — which companies pay providers there.
